A 63-year-old woman presented with progressive congestive heart failure and unexplained cardiomegaly. Diagnostic ARTERIOVENOUS FISTULAE may occur from a variety of causes, and the cardiovascular effects of the altered circulatory state have been well described in the literature.1 2 Renal cell carcinoma with significant arteriovenous shunt formation is an uncommonly encountered entity,3-19 yet it is a reversible cause of hypertension and heart failure.9 We recently had the opportunity of seeing a patient with chronic, severe congestive heart failure secondary to arteriovenous fistulae complicating an unsuspected renal cell carcinoma. The case is being reported and the available English literature reviewed in order to summarize the clinical and cardiovascular manifestations of this disease entity.
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M.L. (SMH #82-41-48) is a 63-year-old woman who was admitted to the Strong Memorial Hospital on October 7, 1972 , with congestive heart failure and pulmonary edema. She had no history of hypertension, valvular heart disease or chest pain. Cardiovascular exam revealed a blood pressure of 175/80 mm Hg, pulse regular at 110 per minute, distended jugular veins, diffuse pulmonary rales, cardiomegaly without heart murmurs, and pitting pre-tibial edema. Routine laboratory studies were unremarkable including a urinanalysis without gross or microscopic hematuria. She responded to digoxin, diuretics, oxygen, and low salt diet. During the course of this hospitalization a systolic bruit was heard over the left flank, but the patient refused an intravenous pyelogram for further evaluation. Twelve days after admission she was discharged in a markedly improved condition.
During the subsequent year, she developed progressive congestive heart failure despite an augmented cardiac regimen. She was readmitted on November 21, 1973 18 The over-all cardiovascular manifestations of the arteriovenous fistulae are dependent on: 1) the magnitude of the shunt as determined by the size of the feeding artery and draining vein and by the level of systemic blood pressure; 2) the chronicity of the fistulae; and 3) the status of the cardiovascular system prior to the development of the fistulae. Thus, one could expect a spectrum of cardiovascular symptoms and signs in this condition as a result of variability in the severity of the aforementioned factors.
There is a paucity of reported data on quantitation of the left-to-right shunt in arteriovenous fistulae complicating renal cell carcinoma. Curtiss et al. '8 reported one patient with a 1.23:1 shunt flow and minimal hemodynamic embarassment. In our patient, sufficient data were not obtained to quantitate the shunt flow; however, it was estimated from the indicator dilution curves, the magnitude of the venous oxygen step up above the renal veins, and the angiographic findings that the shunt was greater than 2:1.
The formation of fistulae in renal cell carcinoma involves multiple connections between arteries and veins due to tumor invasion and the development of communicating vascular spaces within partially necrotic tumor. Although these arteriovenous fistulae are most marked in the primary carcinoma, similar fistulae have been reported in metastatic implants of renal cell carcinoma.22-26 The sparsity of arteriovenous fistulae in other types of malignancy suggests some unique characteristics in the local growth and invasive properties of renal cell carcinoma.
It is quite obvious that total nephrectomy of the involved kidney is the treatment of choice if local tumor extension does not preclude surgery. Even if metastatic lesions exist, and especially if they are solitary, nephrectomy may be indicated to eliminate the hemodynamic burden of the arteriovenous fistulae. The short-term follow-up results of surgical nephrectomy have been excellent from a cardiovascular standpoint with improvement in the congestive heart failure and reduction or normalization of the blood pressure. The long-term results are determined by the growth characteristics of the renal cell carcinoma.
